MELISSA

Mobile Artificial Intelligence Solution for Diabetes Adapted Care

Description

The MELISSA project, a collaboration of 12 partners from seven countries, aims to provide a clinically validated, effective, trustworthy, and cost-efficient artificial intelligence (AI)-based digital diabetes management solution to support both health care providers (HCPs) and insulin-treated patients with diabetes (PwD) in their daily routine with personalised treatment and care recommendations.

Coordinator

Dr Bastiaan de Galan

Universiteit Maastricht

Programme: Horizon Europe & sub-programmes
Duration: 60 months (June 2022 - May 2027)
Project funding: € 7,786,709.00
Project partners: 12
Project website: https://melissa-diabetes.eu/

Your contact

Dr Verena Gluschak

Senior Research & Impact Manager

E-mail